TESTOSTERONE, SLEEP AND YOUR NEXT STEP
TRT does not reliably treat insomnia. Treatment may improve well-being when low testosterone is properly diagnosed, but it can worsen sleep-disordered breathing in some men. Poor sleep can also affect testosterone results. Your sleep history and hormone testing should be considered together.

Medical explanations reviewed by Timothy Mackey, D.O., Medical Director. Previous clinical review: September 2026. Editorial structure and consultation links updated October 30, 2026.
Not predictably. If a man's sleep is being disrupted indirectly by symptoms associated with genuine hypogonadism, successful treatment may improve overall well-being. But randomized evidence does not support prescribing testosterone primarily as a treatment for insomnia.
Persistent insomnia should be evaluated on its own merits, including sleep schedule, medications, alcohol, mental health, restless legs, pain and other contributors.
Discuss your symptoms and sleep history, and whether testosterone testing is appropriate. Poor sleep alone does not establish low testosterone.
Discuss the change with your prescribing clinician rather than changing the dose or timing on your own.
Discuss sleep-apnea evaluation. A testosterone panel does not diagnose a sleep disorder.
Ask about an individualized evaluation and bring your existing hormone results and sleep-treatment information.
Testosterone concentrations follow a daily rhythm and are influenced by sleep. Levels generally rise during sleep and are highest in the morning, which is one reason diagnostic testosterone testing is commonly performed in the morning.
Sleep duration, sleep continuity, circadian timing, age and health status can all influence the measured level. A low testosterone result obtained after major sleep disruption should therefore be interpreted in context rather than automatically treated.
Yes. Experimental sleep restriction has demonstrated reductions in daytime testosterone in healthy young men. One frequently cited study found lower testosterone after a week of restricted sleep, but it was small and should not be interpreted to mean that every lost hour produces a predictable percentage decline.
Adding an hour of sleep does not produce a predictable increase in testosterone. Adequate sleep supports endocrine health, but individual responses vary.
Read the small experimental sleep-restriction study. Its findings do not establish a fixed testosterone change for every hour of sleep lost.
The relationship is uncertain. Men with hypogonadism may experience fatigue, low mood, reduced libido and changes in well-being that coexist with poor sleep, but insomnia has many other causes and is not one of the more specific diagnostic features of testosterone deficiency.
A man with difficulty falling or staying asleep should not assume testosterone is the explanation simply because he also has a borderline hormone result.
Obstructive sleep apnea (OSA) and low testosterone frequently occur together, especially in men with obesity and metabolic disease. Studies associate OSA severity and sleep fragmentation with lower testosterone, but obesity and other shared factors make causality difficult to isolate.
That distinction matters because treating OSA is important for cardiovascular, metabolic and daytime functioning even if testosterone does not rise substantially afterward.
Not reliably. Some individual studies have reported hormonal improvement after treatment of sleep apnea, but systematic reviews and meta-analyses have generally not shown a consistent significant increase in testosterone from CPAP alone.
CPAP should be used when clinically indicated to treat OSA—not as a testosterone-boosting treatment.
A systematic review and meta-analysis of CPAP and testosterone found no significant average change in total testosterone. That does not remove the reasons to treat sleep apnea.
These symptoms do not diagnose OSA. A clinician may recommend formal sleep evaluation or a sleep study when appropriate.
Testosterone can worsen sleep-disordered breathing in some susceptible men, particularly with higher exposures. The Endocrine Society recommends against initiating testosterone in men with untreated severe obstructive sleep apnea.
This does not mean every man with treated OSA is automatically excluded from TRT. It means OSA severity, treatment adherence, symptoms and individual risk should be considered before and during therapy.
See the Endocrine Society guidance, which recommends against starting testosterone in men with untreated severe obstructive sleep apnea.
Treated OSA does not automatically rule out testosterone therapy. The decision should consider OSA control, cardiovascular risk, baseline hematocrit, symptoms, repeat testosterone testing and other contraindications.
Patients should continue prescribed sleep-apnea therapy rather than assuming TRT replaces it.
OSA can contribute to intermittent hypoxia and elevated hematocrit. Testosterone can independently stimulate red-blood-cell production. When both are present, a rising hematocrit deserves careful evaluation rather than simply assuming the testosterone dose is the only cause.
See our guide to hematocrit on TRT.
Formulation and dosing can affect testosterone exposure patterns. Injectable testosterone may produce peaks and troughs depending on dose and interval, while topical formulations provide daily exposure. Some patients report subjective changes in energy or sleep after dose changes, but symptoms should be evaluated rather than used as a reason to chase higher levels.
See our comparison of testosterone creams vs. injections.
Wondering about the twice-yearly clock change? Read our daylight saving time, sleep and testosterone guide for the fall-versus-spring distinction and the limits of the research.
Major chronic sleep problems should be part of the evaluation, but a patient does not need “perfect sleep” before testosterone can ever be measured. The key is recognizing factors that could temporarily suppress the result.
When testosterone is unexpectedly low after acute illness, major sleep deprivation or another transient stressor, repeating the measurement under more representative conditions may help avoid misdiagnosis.
Fatigue and daytime sleepiness are nonspecific. Diagnosis requires compatible symptoms or signs plus consistently low testosterone concentrations measured appropriately. Repeat morning testing is generally recommended.
Evaluation may also include CBC, thyroid testing, metabolic assessment, medication review and sleep-apnea evaluation depending on the presentation. See our TRT blood-testing guide.
Adequate sleep supports normal testosterone physiology, and severe sleep restriction can lower testosterone. But there is no reliable rule that each extra hour of sleep raises testosterone by a specific percentage.
It can contribute to fatigue in men with true hypogonadism, but persistent daytime sleepiness also raises concern for sleep apnea, insufficient sleep, medications and other conditions.
No. TRT is not a treatment for OSA and may worsen sleep-disordered breathing in susceptible patients.
Possibly, depending on severity and treatment status. Untreated severe OSA is an important contraindication in Endocrine Society guidance. Treated OSA requires individualized assessment.
Not every man requires a sleep study before TRT. Men with loud snoring, witnessed apneas, excessive daytime sleepiness or other significant risk factors should discuss sleep evaluation with their clinician.
This article is educational and does not replace individualized medical advice, sleep-disorder diagnosis or treatment.
Speak with NovaGenix about physician-led evaluation, testing, and treatment options in Jupiter, Florida.
Medical disclaimer: This article is for general educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Reading it does not create a physician-patient relationship. Always consult a qualified healthcare professional about your individual circumstances, and never delay seeking care because of something you read here. If you are experiencing a medical emergency, call 911. Read our full Medical Disclaimer.

Request a hormone lab panel. Current NovaGenix patients can request follow-up labs, and new patients can request baseline labs before an evaluation.
Male Hormone Lab Panel: total and free testosterone, sensitive estradiol, hematocrit and PSA at minimum. Dr. Mackey may add TSH, LH, FSH, SHBG, a full CBC or a comprehensive metabolic panel when clinically indicated.
Women's Hormone Lab Panel: CBC, comprehensive metabolic panel, total and free testosterone, estradiol, TSH and progesterone. Dr. Mackey may add FSH, IGF-1, cortisol or other tests when clinically indicated.
Standard hormone lab panels are $125 per panel, billed separately. If additional tests are requested, the price may increase; NovaGenix confirms your total before sending your lab requisition. You then schedule your blood draw with Labcorp at the date, time and location that work best for you.
Request a Lab Panel →
609 North Hepburn Ave, Suite 106, Jupiter, FL 33458
609 North Hepburn Ave, Suite 106, Jupiter, FL 33458
561-277-8260
Learn what you want to know about hormone therapy by scheduling a free consultation.
Contact Us Today609 N Hepburn Ave Ste 106, Jupiter, FL 33458
Monday - Friday: 9:00 am - 5:00 pm | Saturday-Sunday: Closed